Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a change in share interest for Mrs. V. Whyte. On February 4, 2011, she purchased 15 Ordinary shares of GlaxoSmithKline plc at a price of £11.72 per share. This transaction resulted from the reinvestment of dividends on shares held within an Individual Savings Account (ISA).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It strictly adheres to the Disclosure and Transparency Rule 3.1.4R(1)(a) regarding the notification of director transactions.
Key Facts for Investor Verification
- Transaction Date: February 4, 2011.
- Individual Involved: Mrs. V. Whyte.
- Transaction Type: Purchase of 15 Ordinary shares via dividend reinvestment.
- Share Price: £11.72 per Ordinary share.
- Account Type: Individual Savings Account (ISA).
- Notification Date: February 16, 2011.